Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Lexicon Pharmaceuticals, Inc.
(NQ:
LXRX
)
2.190
USD
UNCHANGED
Official Closing Price
/ Updated:
8:10 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Lexicon Pharmaceuticals, Inc.
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Trading Radar for 10/27: Visa (V), Baidu.com (BIDU), WYNN Resorts (WYNN), RF Micro (RFMD), BP (BP) Report
October 26, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5044667 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2009 Financial Results on October 27, 2009
October 20, 2009
from
PR Newswire
Lexicon Announces Completion of Public Offering of Common Stock
October 14, 2009
from
PR Newswire
Lexicon To Offer 30 Million Common Shares
October 09, 2009
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) will offer over 30 million shares of common stock in order to raise approximately $50 million. The stock price fell 27 cents to close at $1.50. ...
Read More
from
MarketMinute.com Stock News
Markets Rise As Trade Deficit Narrows
October 09, 2009
An unexpected drop in the nation's trade deficit in August lifted the markets higher during the midday with the Dow gaining 44 points to 9830. Nasdaq rose 8 points to 2132.
Read More
category
Market News
from
MarketMinute.com Market Updates
Unusual 11 Mid-Day Movers 10/09: SCIL, SRZ, CAGC, IVAN Higher; ACOR, SPPI, LXRX, UCBH Lower
October 09, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5007526 for the full story.
Read More
from
StreetInsider.com News Articles
Morning Movers 10/09: SCIL, MBRX, CAGC, AVNR, PSTA, SRZ, ELGX Higher; SPPI, ACOR, LXRX Lower
October 09, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5007145 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon (LXRX) to Offer 33M Common Shares
October 09, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5006648 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Announces Pricing of Common Stock in Public Offering
October 08, 2009
from
PR Newswire
Thursday's biggest gaining and declining stocks
October 08, 2009
Among the companies whose shares are expected to see active trade in Thursday’s session are the retailers as well as ABB, Alcoa, Barnes & Noble, Corning, Goldman Sachs, Marriott International, Novartis...
Read More
category
CH:ABBN
,
BKS
,
DEST
, and 23 more.
from
MarketWatch
After-Hours Movers 10/07: SCSC, HOTT, TGIC, AA, CPKI Higher; LXRX, SVNT Lower
October 07, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5002974 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharma (LXRX) Files 27.5M Share Shelf Offering
October 07, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5002693 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Announces Proposed Offering of 27,500,000 Shares of Common Stock
October 07, 2009
from
PR Newswire
Stock on the Move: SUWN -- September 16, 2009
September 16, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC.
Read More
from
Marketwired News Releases
Stocks to Watch for Wednesday, September 16, 2009: ARYC -- Arrayit Corporation Wins Manufacturing Contract From the Centers for Disease Control in Atlanta, Georgia!
September 16, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.
Read More
from
Marketwired News Releases
Lexicon Reports Positive Drug Trial Data
September 15, 2009
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) posted positive phase 1 results for its drug candidate that treats diabetes sending the stock price soaring $1.29 to $2.91. ...
Read More
from
MarketMinute.com Stock News
Unusual 11 Mid-Day Movers 9/15: FNET, LXRX, DIET, CLFD Higher; ZOOM, FTWR, NTWK, AMIE Lower
September 15, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4945818 for the full story.
Read More
from
StreetInsider.com News Articles
Piper Says Today's Rally in Lexicon (LXRX) is Overdone; Reiterates Underweight
September 15, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4945633 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals Shares Jump 115% on Drug News
September 15, 2009
Lexicon Pharmaceuticals Shares Jump 115% on Drug News
Read More
category
Retail
from
FOXBusiness.com
Morning Movers 9/15: LXRX, AMTY, DIET, DARA, BCRX Higher; ZOOM, NTWK, GRT, ARNA Lower
September 15, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4945109 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Surges On Positive Early Trials, Move to Phase 2
September 15, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4945097 for the full story.
Read More
from
StreetInsider.com News Articles
Stocks Open Mixed as Retail Sales Surge
September 15, 2009
Retail sales rose by a better than expected 2.7% in August, but wholesale prices surged which worried some investors. The Dow slipped 4 points to 9622 while Nasdaq held steady at 2090.
Read More
category
Market News
from
MarketMinute.com Market Updates
Early Market Movers: Parallel Petroleum, B&G Foods
September 15, 2009
Early Market Movers: Parallel Petroleum, B&G Foods
Read More
category
Markets
from
FOXBusiness.com
Lexicon Pharma (LXRX) Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
September 15, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4943895 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
September 15, 2009
from
PR Newswire
Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
September 09, 2009
from
PR Newswire
Lexicon Pharmaceuticals (LXRX) Files To Sell Up To $150M
September 02, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4919150 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
September 02, 2009
from
PR Newswire
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
August 04, 2009
from
PR Newswire
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
July 28, 2009
from
PR Newswire
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here